ir.intelliatx.com ir.intelliatx.com

IR.INTELLIATX.COM

Intellia Therapeutics - Investor Relations

Intellia is a leading genome editing company, focused on the development of potentially curative therapeutics utilizing the CRISPR/Cas9 system. The Company’s mission is to develop gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. January 11, 2017. Intellia Therapeutics Joins Genomics England’s Industry Consortium. December 16, 2016. December 13, 2016. Intellia Therapeutics Names Graeme Bell Chief Financial Officer. Trout Group, LLC.

http://ir.intelliatx.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.INTELLIATX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.3 out of 5 with 7 reviews
5 star
2
4 star
2
3 star
1
2 star
0
1 star
2

Hey there! Start your review of ir.intelliatx.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.9 seconds

FAVICON PREVIEW

  • ir.intelliatx.com

    16x16

CONTACTS AT IR.INTELLIATX.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Intellia Therapeutics - Investor Relations | ir.intelliatx.com Reviews
<META>
DESCRIPTION
Intellia is a leading genome editing company, focused on the development of potentially curative therapeutics utilizing the CRISPR/Cas9 system. The Company’s mission is to develop gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. January 11, 2017. Intellia Therapeutics Joins Genomics England’s Industry Consortium. December 16, 2016. December 13, 2016. Intellia Therapeutics Names Graeme Bell Chief Financial Officer. Trout Group, LLC.
<META>
KEYWORDS
1 menu
2 about us
3 overview
4 leadership
5 partners
6 crispr/cas9
7 strategy
8 pipeline
9 extellia
10 newsroom
CONTENT
Page content here
KEYWORDS ON
PAGE
menu,about us,overview,leadership,partners,crispr/cas9,strategy,pipeline,extellia,newsroom,investor relations,press releases,events and presentations,corporate governance,financial information,stock information,investor faqs,information request,careers
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Intellia Therapeutics - Investor Relations | ir.intelliatx.com Reviews

https://ir.intelliatx.com

Intellia is a leading genome editing company, focused on the development of potentially curative therapeutics utilizing the CRISPR/Cas9 system. The Company’s mission is to develop gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. January 11, 2017. Intellia Therapeutics Joins Genomics England’s Industry Consortium. December 16, 2016. December 13, 2016. Intellia Therapeutics Names Graeme Bell Chief Financial Officer. Trout Group, LLC.

SOCIAL ENGAGEMENT



OTHER SITES

ir.inovio.com ir.inovio.com

Inovio Pharmaceuticals - Investors - Overview

Inovio In The News. Investor News and Media. Financial Reports and Filings. Quarterly and Annual Reports. Code of Business Conduct and Ethics. Board Committee Composition and Charters. Contact the Board of Directors. Investigator Conflict of Interest Policy. Inovio is revolutionizing the fight against cancer and infectious diseases. Inovio Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call August 10, 2015. 2Q 2015 Financial Results Conference Call. August 10, 2015. 660 West Ger...

ir.inspirepharm.com ir.inspirepharm.com

Non-Existent Domain

Your browser does not support iframes, please click here.

ir.intai.com.tw ir.intai.com.tw

鐿鈦科技 INTAI

Sp@mail.intai.com.tw.

ir.integrysgroup.com ir.integrysgroup.com

IRWeblink

Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.

ir.inteliquent.com ir.inteliquent.com

Press Releases - Inteliquent

Direct Inward Dial (DID). Law Enforcement and Subpoenas. 10 results per page. 25 results per page. 50 results per page. GTCR Completes Acquisition of Inteliquent. File is in Briefcase. Inteliquent Reports Third Quarter 2016 Results. Financial and operating highlights include: Company agrees to be acquired by GTCRCompany invests in Zipwhip, a Seattle-based business texting SaaS companyThird quarter 2016 minutes of use increased 55.0% compared to third quarter of 2015Third quarter 2016 revenue increa.

ir.intelliatx.com ir.intelliatx.com

Intellia Therapeutics - Investor Relations

Intellia is a leading genome editing company, focused on the development of potentially curative therapeutics utilizing the CRISPR/Cas9 system. The Company’s mission is to develop gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. January 11, 2017. Intellia Therapeutics Joins Genomics England’s Industry Consortium. December 16, 2016. December 13, 2016. Intellia Therapeutics Names Graeme Bell Chief Financial Officer. Trout Group, LLC.

ir.interceptpharma.com ir.interceptpharma.com

Investors - Intercept Pharmaceuticals, Inc.

4:00 PM ET on Aug 14, 2015. Delayed at least 20 minutes. Aug 5, 2015. Intercept Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Business Update. Jul 29, 2015. Intercept to Report Second Quarter 2015 Financial Results on August 5 and Present at Upcoming Conferences. View all press releases. Recent Events and Presentations. Aug 11, 2015 at 10:55 AM ET. 2015 Wedbush PacGrow Healthcare Conference. Aug 5, 2015 at 4:30 PM ET. Second Quarter 2015 Financial Results and Conference Call.

ir.interchangeusa.com ir.interchangeusa.com

Local Corporation - Investors - Financial Information

Consumer Sites and Apps. Data as of 08/05/15 4:00 pm ET. Minimum 20 minute delay. Local Corporation (NASDAQ:LOCM) is a leading local advertising technology company that connects millions of online and mobile consumers with businesses and products through a variety of innovative digital advertising solutions. Q1 2015 Local Corporation Earnings Presentation. Local Corporation Reports First Quarter 2015 Financial Results. Local Corporation to Announce First Quarter 2015 Financial Results. Rocket Fuel’s Audi...

ir.intercloudsys.com ir.intercloudsys.com

Investor Relations :: InterCloud Systems, Inc. (ICLD)

Investor Relations: 561-988-1988 , Customer Service : 888-908-1866. InterCloud Systems Contracted to Deploy Next Generation Core Data Center Network and Virtualized SIP Voice Network Solution for the City of Yonkers. Aug 13, 2015. Jun 30, 2015. Sign up for email alerts. Be the first to receive breaking news. InterCloud Systems, Inc. Corporate Stock Transfer, Inc. 3200 Cherry Creek Drive South. Denver, CO 80209. Officers & Directors. Chairman of the Board, Chief Executive Officer. Scott R. Davis. Mr Sulli...

ir.interdigital.com ir.interdigital.com

Corporate Profile | InterDigital.com

Annual Reports and Proxy Statements. Financial metrics tracker for Q4 2017. 035 - 0.48%. Market Cap $ M. As of March 29, 2018. Mar 21, 2018. InterDigital Wins 5G Smart Tourism Bid. Mar 20, 2018. InterDigital CEO: Representatives Stivers and Foster Spur American Innovation With New Stronger Patents Act. Mar 19, 2018. InterDigital Announces Successful oneM2M Hackathon Dallas 2018. Fourth Quarter and Full Year 2017 Financial Results Conference Call. February 22, 2018. Patrick Van de Wille. It is your respon...

ir.interlinebrands.com ir.interlinebrands.com

Investors - Interline Brands, Inc.

Interline Brands, Inc. Is a leading distributor and direct marketer with headquarters in Jacksonville, Florida. Jul 31, 2015. Interline Brands Announces Second Quarter and Year-To-Date 2015 Sales and Earnings Results. Jul 22, 2015. Interline Brands to be Acquired by The Home Depot. Q1 2015 IR Presentation. May 27, 2015. Q1 2015 IR Presentation. Feb 26, 2015. Q4 2014 IR Presentation. There are currently no events scheduled. Our family of brands. 2015 Interline Brands, Inc.